Advertisement
Screener

ANAVEX LIFE SCIENCES CORP. (AVXL) Form D

ANAVEX LIFE SCIENCES CORP. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-04-02: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-03-18; Total offering amount $10,000,000.
  • 2012-02-16: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2012-02-09; Total offering amount $10,000.
  • 2010-11-26: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2010-11-17; Total offering amount $49,500.
  • 2010-07-06: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2010-06-29; Total offering amount $500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-04-02Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired2014-03-18$10,000,000$10,000,000$011
2012-02-16Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2012-02-09$10,000$10,000$01
2010-11-26Rule 506Equity; OptionToAcquire2010-11-17$49,500$49,500$01
2010-07-06Rule 506Equity; OptionToAcquire2010-06-29$500,000$500,000$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95